A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of ...

Moderna Inc. Chief Executive Officer Stephane Bancel said he sees the pending launch of a planned flu vaccine as a chance to ...

By Julie Steenhuysen CHICAGO, June 9 (Reuters) - Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly ...

An experimental mRNA vaccine delayed neuroblastoma growth and sharply reduced tumor size in preclinical models.

A Food and Drug Administration advisory panel on Thursday recommended the approval of Moderna’s mRNA-based flu shot for older ...

Breaking news and analysis from time.com. Politics, world news, photos, video, tech reviews, health, science, and entertainment news.

Moderna just received fantastic news.

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly ...

Researchers developed an mRNA vaccine targeting glypican-2, a protein found on neuroblastoma cells. In preclinical studies, ...

India, June 23 -- The US Food and Drug Administration's (FDA) independent vaccine advisory committee has recommended approval ...

Preclinical study demonstrates effectiveness of experimental mRNA vaccine against neuroblastoma, reducing tumour size by 70 ...